Dr. Hoshang Farhad, MD

Dr. Farhad practices at Cardiovascular Institute of New England - HOPD in Lincoln, Rhode Island.

Dr. Farhad's NPI, 1760902530, was assigned on June 22, 2017. Dr. Farhad holds Rhode Island license MD19848.

Dr. Farhad's primary practice is Cardiovascular Institute of New England - HOPD, at 6 Blackstone Valley Place, Lincoln, RI 02865.

Dr. Farhad's primary practice is Cardiovascular Institute of New England - HOPD in Lincoln, Rhode Island. Dr. Farhad is also affiliated with The Miriam Hospital. The medical group on file is Cardiovascular Institute of New England. Dmand AI also links Dr. Farhad to 3 more hospitals, 2 group practices and clinics and 2 medical groups, each named with a free account. Dr. Farhad's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Farhad practices, 7 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Farhad's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Farhad is licensed in Rhode Island.

CMS data shows 224 Medicare services from Dr. Farhad across 8 procedure codes in 2024, for 113 Medicare patients. Medicare paid $21,396 for them.

CMS counts 113 Medicare patients who saw Dr. Farhad in 2024. The largest group is 75 to 84, with 51 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 12% are also on Medicaid. Their average risk score is 1.69, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Farhad's median patient age at 71, with 48% women.

In 2024, Dr. Farhad wrote 425 Medicare Part D claims for 139 patients. 82% of them were for generic drugs. CMS names the drug for 340 of them, across 10 drugs with 11 or more claims each, at $81,594 in total drug cost. In 2023, CMS named 223 claims across 7 drugs.

Dr. Farhad accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 19 procedures of coronary angioplasty and stenting by Dr. Farhad, more than 48% of the clinicians it reports for that procedure.

Dmand AI links 18 papers to Dr. Farhad, published from 2013 to 2018. 2013 was the busiest year, with 5. The most frequent topics are Magnetic Resonance Imaging, Predictive Value of Tests and Atrial Fibrillation. Dr. Farhad has published most often in J Am Heart Assoc. Dr. Farhad's most frequent co-authors are Siddique Abbasi, MD, Raymond Y. Kwong, MD and John Adams Dodson, MD.

CMS Open Payments shows 31 general payments to Dr. Farhad from 11 drug and device companies from 2020 to 2025. Food and beverage make up the largest share, 43% of the total. Abbott Laboratories paid the most, $957.